Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia J. Burgos, V. Falcó, A. Borrego, R. Sordé, M.N. Larrosa, X. Martinez, A.M. Planes, A. Sánchez, M. Palomar, J. Rello, A. Pahissa Clinical Microbiology and Infection Volume 19, Issue 4, Pages 385-391 (April 2013) DOI: 10.1111/j.1469-0691.2012.03895.x Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions
Fig. 1 Incidence of the invasive pneumococcal pneumonia by years, serotype groups and age. Clinical Microbiology and Infection 2013 19, 385-391DOI: (10.1111/j.1469-0691.2012.03895.x) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions
Fig. 2 Serotypes causing IPP in the pre and post-vaccine periods by age groups. Clinical Microbiology and Infection 2013 19, 385-391DOI: (10.1111/j.1469-0691.2012.03895.x) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions